Tag: drug-coated balloon
Medtronic commences Prevail Global study as it seeks coronary DCB approvals in USA and Japan
Medtronic has announced that the first patient has been enrolled in its pivotal trial of the Prevail...
How using DCBs can “open up a new world” for PCI
Early exposure to the use of drug-coated balloons (DCBs) for percutaneous coronary intervention ...
Cordis announce positive 24-month results from Selution SFA Japan trial
Cordis has announced positive 24-month results from the Selution SFA Japan trial. The prospective, m...
ADVERTORIAL: Ready for the primetime? The future role of drug-coated balloons in PCI
This advertorial is sponsored by B Braun Melsungen AG
“The evolution of PCI has always been a co...
Enrolment completed in TRANSFORM 1 trial of MagicTouch DCB
Concept Medical has announced the successful completion of the TRANSFORM 1 RCT. The randomised c...
Cardionovum’s coronary DCB receives regulatory approval in China
Cardionovum's Restore paclitaxel-coated balloon for coronary applications has received market ap...
SeQuent Please ReX drug-coated PTCA balloon catheter receives FDA breakthrough device designation
B Braun Interventional Systems has announced that the US Food and Drug Administration (FDA) has gran...
Sirolimus-coated balloon “may represent a new approach to treating in-stent restenosis”
Stefan Verheye (Antwerp Cardiovascular Centere ZNA Middelheim, Interventional Cardiology, Antwerp, B...
Negative late lumen loss at 24 months for TriReme Chocolate Heart
TriReme Medical, a subsidiary of QT Vascular, has announced that its angiographic data from a 24...
Drug-coated scoring balloon receives CE mark
Spectranetics has been granted the CE mark for its AngioSculptX Drug-coated percutaneous coronary tr...
